Monica Schenone
Pfizer (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Prostate Cancer Treatment and Research, Mechanisms of cancer metastasis, Protein Degradation and Inhibitors, Acute Myeloid Leukemia Research
Most-Cited Works
- → Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells(2013)1,799 cited
- → Target identification and mechanism of action in chemical biology and drug discovery(2013)1,077 cited
- → Selective killing of cancer cells by a small molecule targeting the stress response to ROS(2011)1,028 cited
- → WRN helicase is a synthetic lethal target in microsatellite unstable cancers(2019)456 cited
- → The NORAD lncRNA assembles a topoisomerase complex critical for genome stability(2018)399 cited
- → Identifying the proteins to which small-molecule probes and drugs bind in cells(2009)307 cited
- → Phenotypic drug discovery: recent successes, lessons learned and new directions(2022)303 cited
- → Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9(2016)245 cited
- → The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer(2020)172 cited
- → Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms(2017)158 cited